Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

(2022) Isabel Graupera et al.   BMC PUBLIC HEALTH

Association of Weight Changes With Changes in Histological Features and Blood Markers in Nonalcoholic Steatohepatitis

(2021) Dimitrios A. Koutoukidis et al.   Clinical Gastroenterology and Hepatology

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update

(2021) Annalisa Berzigotti et al.   JOURNAL OF HEPATOLOGY

Liver cirrhosis

(2021) Pere Ginès et al.   LANCET

Baveno VII – Renewing consensus in portal hypertension

(2021) Roberto de Franchis et al.   JOURNAL OF HEPATOLOGY

The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

(2021) Tom H Karlsen et al.   LANCET

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

(2021) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2020) Sadaf G Sepanlou et al.   Lancet Gastroenterology & Hepatology

Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis

(2020) Anton L.V. Avanceña et al.   JOURNAL OF HEPATOLOGY

Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia

(2019) Miquel Serra-Burriel et al.   JOURNAL OF HEPATOLOGY

High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study

(2018) Llorenç Caballería et al.   Clinical Gastroenterology and Hepatology

Range of Normal Liver stiffness and Predictors of Suspected Advanced Fibrosis in Apparently Healthy Individuals: A Pooled Analysis of 16,082 Participants

(2018) Fateh Bazerbachi et al.   Clinical Gastroenterology and Hepatology

Burden of Liver Diseases in the World

(2018) Sumeet K. Asrani et al.   JOURNAL OF HEPATOLOGY

Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study

(2018) Núria Fabrellas et al.   PLoS One

Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease

(2017) Carolin Lackner et al.   JOURNAL OF HEPATOLOGY

Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis

(2016) Maja Thiele et al.   GASTROENTEROLOGY

Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography

(2015) D. J. Harman et al.   BMJ Open

UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age

(2015) Cathie Sudlow et al.   PLOS MEDICINE

Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2013) Paul Angulo et al.   GASTROENTEROLOGY

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

(2011) Vincent Wai-Sun Wong et al.   GUT

Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years

(2010) D. Roulot et al.   GUT